カテゴリ： MarketLine, イギリス, 企業調査

Guardian Media Group plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Guardian Media Group plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C8883
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：メディア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Guardian Media Group plc – Strategy, SWOT and Corporate Finance Report
Summary

Guardian Media Group plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Guardian Media Group plc (GMG or “the company”) is one of the leading media organizations. Its core business includes the operations of Guardian News & Media (GNM), the publisher of theguardian.com, the Guardian and the Observer newspapers. The company primarily operates in the UK. It is headquartered in London, the UK.

Scope

- Detailed information on Guardian Media Group plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Guardian Media Group plc in the form of a SWOT analysis
- An in-depth view of the business model of Guardian Media Group plc including a breakdown and examination of key business segments
- Intelligence on Guardian Media Group plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Guardian Media Group plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Guardian Media Group plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Guardian Media Group plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Guardian Media Group plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Guardian Media Group plc: Company Overview 9
Guardian Media Group plc: Overview and Key Facts 9
Guardian Media Group plc: Overview 9
Guardian Media Group plc: Key Facts 9
Guardian Media Group plc: Key Employees 10
Guardian Media Group plc: Key Employee Biographies 12
Guardian Media Group plc: Major Products and Services 18
Guardian Media Group plc: Company History 19
Guardian Media Group plc: Management Statement 23
Guardian Media Group plc: Locations and Subsidiaries 24
Guardian Media Group plc: Key Competitors 25
Guardian Media Group plc: Company Analysis 26
Guardian Media Group plc: Business Description 26
Guardian Media Group plc: SWOT Analysis 27
Guardian Media Group plc: SWOT Overview 27
Guardian Media Group plc: Strengths 27
Guardian Media Group plc: Weaknesses 28
Guardian Media Group plc: Opportunities 28
Guardian Media Group plc: Threats 29
Guardian Media Group plc: Corporate Financial Deals Activity 31
Guardian Media Group plc: Financial Deals Overview 31
Guardian Media Group plc: Targets and Partners 33
Guardian Media Group plc: Top Deals 2014 – 2018YTD* 34
Guardian Media Group plc: Advisors 35
Guardian Media Group plc: Top Legal Advisors 35
Guardian Media Group plc: Top Financial Advisors 35
Guardian Media Group plc: Mergers and Acquisitions 36
Guardian Media Group plc: Corporate Venturing 37
Guardian Media Group plc: Divestments 38
Guardian Media Group plc: Recent Developments 39
Guardian Media Group plc: News and Events Summary 39
Guardian Media Group plc: Business Expansion 42
Guardian Media Group plc: Contracts 43
Guardian Media Group plc: Corporate Governance 44
Guardian Media Group plc: Financial Performance 44
Guardian Media Group plc: Market Developments 45
Guardian Media Group plc: Red Flags/DistressSignals 45
Guardian Media Group plc: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Guardian Media Group plc: Key Facts
Table 2: Guardian Media Group plc: Key Employees
Table 3: Guardian Media Group plc: Company History
Table 4: Guardian Media Group plc: Locations and Subsidiaries
Table 5: Guardian Media Group plc: Key Competitors
Table 6: Guardian Media Group plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Guardian Media Group plc: M&A Activity by Geography (TTM*)
Table 8: Guardian Media Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Guardian Media Group plc: M&A Average Deal Size - Value (US$m)
Table 10: Guardian Media Group plc: Targets and Partners
Table 11: Guardian Media Group plc: Top Deals 2014 - 2018YTD*
Table 12: Guardian Media Group plc: Legal Advisor Ranking by Value (US$m)
Table 13: Guardian Media Group plc: Financial Advisor Ranking by Value (US$m)
Table 14: Guardian Media Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Guardian Media Group plc: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Guardian Media Group plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 17: Guardian Media Group plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 18: Guardian Media Group plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Guardian Media Group plc: Divestments by Geography (2014 - YTD*2018)
Table 20: Guardian Media Group plc: News and Events Summary
Table 21: Guardian Media Group plc: Business Expansion
Table 22: Guardian Media Group plc: Contracts
Table 23: Guardian Media Group plc: Corporate Governance
Table 24: Guardian Media Group plc: Financial Performance
Table 25: Guardian Media Group plc: Market Developments
Table 26: Guardian Media Group plc: Red Flags/DistressSignals
Table 27: Guardian Media Group plc: Strategy and Operations

List of Figures
Figure 1: Guardian Media Group plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Guardian Media Group plc: M&A Activity by Geography (TTM*)
Figure 3: Guardian Media Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Guardian Media Group plc: M&A Average Deal Size - Value (US$m)
Figure 5: Guardian Media Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Guardian Media Group plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Guardian Media Group plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Guardian Media Group plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Guardian Media Group plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Guardian Media Group plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Guardian Media Group plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Samsung Electronics Co Ltd (005930)：電力：M&Aディール及び事業提携情報
    Summary Samsung Electronics Co Ltd (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, …
  • GRI Bio Inc-製薬・医療分野：企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …
  • 21st Century Oncology Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …
  • Banca Del Ceresio SA：企業の戦略・SWOT・財務分析
    Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report Summary Banca Del Ceresio SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • IMV Inc (IMV)：企業の財務・戦略的SWOT分析
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a biopharmaceutical company that develops immunotherapies and vaccines to treat cancer and infectious diseases. The company is investigating its pipeline candidates DPX-Survivac against ovarian, bladder, liver, non-small cell lung cancer and diff …
  • MEDITE Cancer Diagnostics Inc (MDIT)-医療機器分野：企業M&A・提携分析
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • SalvaRx Group plc (SALV)：企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Aster DM Healthcare (ASTERDM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as mobile medical units, cardiac surgery, early cancer detection centers, village adoption, and dialys …
  • China State Shipbuilding Corp：企業の戦略・SWOT・財務情報
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MPI Research Inc-製薬・医療分野：企業M&A・提携分析
    Summary MPI Research Inc (MPI) is a contract research company that provides preclinical and early clinical research services. The company’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services, medical device evaluation, tran …
  • Archer Ltd (ARCHER)：石油・ガス：M&Aディール及び事業提携情報
    Summary Archer Ltd (Archer) is an oilfield services company. It provides drilling services, well integrity and intervention, plug and abandonment and decommissioning. Its drilling and work-over services include platform drilling, land drilling, modular rigs, drilling fluids, solids control, engineer …
  • Oasis Petroleum Inc (OAS)：企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lidco Group Plc (LID)：企業の製品パイプライン分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company's product portfolio include LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive c …
  • Synthetic Biologics Inc (SYN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • SVB Financial Group：企業の戦略・SWOT・財務情報
    SVB Financial Group - Strategy, SWOT and Corporate Finance Report Summary SVB Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • Fortune Brands Home & SecurityInc：戦略・SWOT・企業財務分析
    Fortune Brands Home & SecurityInc - Strategy, SWOT and Corporate Finance Report Summary Fortune Brands Home & SecurityInc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Gas Natural Fenosa：企業のM&A・事業提携・投資動向
    Gas Natural Fenosa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gas Natural Fenosa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • PendoPharm Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary PendoPharm Inc (PendoPharm), a subsidiary of Pharmascience Inc, is a healthcare company that provides production and commercialization of a wide range of drugs. The company provides products such as spans prescription drugs, over-the-counter and behind-the-counter products, among others. Its …
  • Bio Blast Pharma Ltd (ORPN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆